UBS Group »

Psyence Biomedical shares owned by UBS Group

Quarter-by-quarter ownership of Psyence Biomedical (PBM) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Psyence Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Psyence Biomedical held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Psyence Biomedical by UBS Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $757 1.0k 0.75
2025-06-30 $10k 2.0k 5.33

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Ubs Group SHS (UBS)
Ishares Tr Russell 2000 Etf (IWM)
Spdr Gold Tr Gold Shs (GLD)
Tesla Motors (TSLA)

View all positions for UBS Group

Top funds holding Psyence Biomedical

Parallel Advisors
Virtu Financial
AdvisorShares Investments
Advisor Group Holdings
UBS Group
Stonehage Fleming Financial Services Holdings

View all funds holding Psyence Biomedical